LIM
UTHR icon

Leavell Investment Management’s United Therapeutics UTHR Stock Holding History

Leavell Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Hold
628
– – 0.01% 509
2026
Q1 		$372K Buy
628
+79
+14% +$39.3K 0.02% 470
2025
Q4 		$268K Buy
549
+12
+2% +$5.59K 0.01% 531
2025
Q3 		$225K Buy
+537
New +$181K 0.01% 551
2015
Q4 		– Sell
-2,300
Closed -$302K – 375
2015
Q3 		$302K Hold
2,300
– – 0.05% 306
2015
Q2 		$400K Hold
2,300
– – 0.06% 274
2015
Q1 		$397K Hold
2,300
– – 0.06% 282
2014
Q4 		$298K Buy
2,300
+500
+28% +$64.4K 0.05% 324
2014
Q3 		$232K Buy
+1,800
New +$186K 0.04% 355

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

Leavell Investment Management's UTHR Position: Q2 2026 in Review

Leavell Investment Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 628 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #509.

Leavell Investment Management first reported a position in UTHR in Q3 2014 and has held it in 9 quarters since. The position peaked at $400K in Q2 2015. 140 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Leavell Investment Management held 628 shares of United Therapeutics worth $340K as of Q2 2026.
  • Leavell Investment Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.01% of Leavell Investment Management's portfolio in Q2 2026, its #509 holding.
  • Leavell Investment Management first reported a position in United Therapeutics in Q3 2014 and has held it in 9 quarters since.
  • Leavell Investment Management's United Therapeutics position peaked at $400K in Q2 2015.
  • 140 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.